Research rounds up key issues in high-cost randomized controlled trials, indicating limitations in clinical decisions.
No abstract yet. The journal hasn't published one we can show.
No takes yet. Share an insight, caveat, or question.
Justin Morgenstern (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: